JUNE 2-6, 2023,ASCO Annual Meeting (Chicago, IL) Future Meetings MAY 31 - JUNE 4, 2024 Chicago, IL 您对未来癌症护理的全通行证从这里开始。或者,您可以下载以下年会计划资源: ASCO 年会会议一览表 浏览计划公告以了解会议亮点、特色会议以及如何注册。 您对临床上最相关的癌症科学
| chicago, il subscribe for updates arrow_back_ios arrow_forward_ios most viewed text_snippet videos & slides 2023 asco annual meeting phase ii trial of neoadjuvant osimertinib for surgically resectable egfr -mutated non-small cell lung cancer. first author: jacqueline v. aredo, md, ms text_...
The ASCO Annual Meeting features the latest research news and policy updates across oncology. May 31-June 4, 2024 McCormick Place | Chicago, IL Breast Cancer What’s Ribociclib’s Current Role in Breast Cancer? Erin Frances Cobain, MD; Stephanie Graff, MD ...
Therefore, the year 2023 saw the presentation of clinically relevant data in several areas during the K Congress update 2023—ASCO and ESMO 71 editorial respective annual conferences of ASCO and ESMO and once more emphasized the continued relevance of these large meetings in parallel to disease-...
The ASCO annual meeting is the world’s preeminent meeting of oncology professionals. Giving an oral presentation at the ASCO annual meeting is a landmark in a career. We examined the training and geographic diversity of presenters...
“We went from using radiation in more than half of the youngest patients to barely using it at all,” said Herrera about the trial in an interview with OncLive® News Network: On Location during the 2023 ASCO Annual Meeting. “Hopefully, [use of this regimen is] going...
ASCO 20236/2/2023 - 6/6/2023Chicago IL, United States ASCO 20226/3/2022 - 6/7/2022Chicago IL, United States ASCO 20186/1/2018 - 6/5/2018Chicago IL, United States Related Events: Annual Conference on Shock 2025 5/31/2025 - 6/3/2025 ...
The International Association for the Study of Lung Cancer (IASLC) is a global multidisciplinary organization dedicated to the eradication of lung cancer and other thoracic malignancies. Among the many excellent conferences IASLC organizes is the annual World Conference on Lung Ca...
在2023年欧洲肿瘤内科学会亚洲大会(ESMO Asia)上,吴一龙教授汇报了氟泽雷塞针对我国NSCLC患者的一项临床II期注册研究。初步研究结果显示,氟泽雷塞治疗KRAS G12C突变晚期NSCLC的确认ORR(cORR)为46.6%,DCR为90.5%,中位无进展生存期(mPFS)为8...
By The ASCO Post Staff / May 25, 2023 - Supplement: Conference Highlights SGO 2023 / SGO 2023 Annual Meeting on Women’s Cancer Expert Point of View: Carol Aghajanian, MD Carol Aghajanian, MD, Chief of the Gynecologic Medical Oncology Service at Memorial Sloan Kettering Cancer Center, New...